Research output per year
Research output per year
Personal profile
Fingerprint
Dive into the research topics where Matthias Moser is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Most recent collaborations and top research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Assessment of ctDNA detection in prostate cancer using a 6-base epigenomics and fragmentomics approach.
Huynh, T., Sadeghi, H., Mischinger, J., Moser, T., Moser, M., Vlachos, G., Mejia Pedroza, R., Heitzer, E. & Charlesworth, T., 2026, In: Journal of Clinical Oncology. 44, 16_SUPPL, p. e17132-e17132 1 p., e17132.Research output: Contribution to journal › Conference abstract
-
The best from both disciplines: integrating human and microbial signatures from whole genome sequencing to advance cancer diagnostics.
Moser, T. (First author), Moser, M. & Mahnert, A., 20 Jan 2026, In: mSystems. 11, 1, p. e0003924 12 p.Research output: Contribution to journal › Review
-
Assessment of ctDNA detection in prostate cancer using an epigenomics and fragmentomics approach.
Sadeghi, H., Vlachos, G., Moser, T., Moser, M., Mejia Pedroza, R., Mischinger, J. & Heitzer, E., 2025.Research output: Contribution to conference book › Conference article
-
Evaluation of urinary cfDNA workflows for the molecular profiling of malignant disease
Eberhard, A. (First author), Moser, T., Ziegler, L., Vlachos, G., Loibner, M., Bauernhofer, T., Balic, M., Gerger, A., Dandachi, N., Beichler, C., Glawitsch, L., Moser, M., Graf, R., Abuja, P. M., Schmitz, M., Krenz, T., Voss, T., Mancarella, D. & Heitzer, E., 17 Oct 2025, In: iScience. 28, 10, p. 113632 17 p.Research output: Contribution to journal › Research article
4 Citations (Web of Science) -
Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer
Bauernhofer, E., Moser, T., Eberhard, A., Monsberger, N., Moser, M., Glawitsch, L., Hammer, S., Vlachos, G., Ziegler, L., Geigl, J. B., Bauernhofer, T. & Heitzer, E., 2025, In: Annals of Oncology.Research output: Contribution to journal › Conference abstract
-
Assessment of ctDNA detection in prostate cancer using an epigenomics and fragmentomics approach.
Sadeghi, H. (Speaker), Vlachos, G. (Author), Moser, T. (Author), Moser, M. (Author), Mejia Pedroza, R. (Author), Mischinger, J. (Author) & Heitzer, E. (Author)
2025Activity: Talk, presentation or poster › Poster
-
Fragmentomics Holds Firm Across Sites: A PANCAID Benchmark.
Moser, M. (Speaker), Moser, T. (Author), Graf, R. (Author), Sadeghi, H. (Author), Magenheim, J. (Author), Smit, D. (Author), Schneegans, S. (Author), Pantel, K. (Author), Loehr, M. (Author), Malats, N. (Author), Andueza, M. (Author), Soeth, E. (Author), Sebens, S. (Author), Kaplan, T. (Author), Dor, Y. (Author) & Heitzer, E. (Author)
2025Activity: Talk, presentation or poster › Poster
-
Fast-Track to PARPi: cfDNA Fragmentomics as an HRR Mutation Screen in Prostate Cancer.
Moser, M. (Speaker), Vlachos, G. (Author), Moser, T. (Author), Bauernhofer, T. (Author) & Heitzer, E. (Author)
2025Activity: Talk, presentation or poster › Poster
-
Multimodales Liquid Profiling.
Spiegl, B. G. (Speaker), Moser, T. (Author) & Moser, M. (Author)
2025Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Plasma-derived ctDNA outperforms urinary ctDNA as a prognostic biomarker in metastatic prostate cancer
Bauernhofer, E. (Author), Moser, T. (Author), Eberhard, A. (Author), Monsberger, N. (Author), Moser, M. (Author), Glawitsch, L. (Author), Hammer, S. (Author), Vlachos, G. (Author), Ziegler, L. (Author), Geigl, J. B. (Author), Bauernhofer, T. (Author) & Heitzer, E. (Author)
2025Activity: Talk, presentation or poster › Poster